Welcome to the Respiratory Huddle

PMD has officially been reviewed and selected as one of the 13 out of 20 companies identified by the National Institute for Health and Care Excellence to provide services to patients on a virtual ward platform.  A virtual ward platform comprises of technology through a patient-facing app or website, using medical devices for measuring vital signs whilst patients remain in the comfort of their own homes. The patient's vital signs are monitored remotely by healthcare professionals.

The Massachusetts Medical Device Industry Council (MassMEDIC) is proud to announce the 2023 cohort of the MedTech IGNITE Program (IGNITE), an accelerator program for medtech entrepreneurs, designed and supported by the medtech industry. IGNITE offers a robust calendar of workshops and networking opportunities in a newly-redesigned intensive 3-month program that runs from September – November 2023.

Brussels, 5 May 2023 - The European Federation of Allergies and Airways Diseases (EFA) awarded last week the first edition of the EFA Patients’ Digital Prize for e-health technologies for asthma and chronic obstructive pulmonary disease (COPD) care. Whether they are connected medical devices, telemedicine, e-health apps or digital health platforms, chronic respiratory disease patients need to be at the core of the technologies that support them self-managing their care and getting support from their healthcare professionals. This was the principle behind the work of the jury¹, which selected one winner in each of the three competition categories: AsthmaTuner by Medituner AB won in the best digital technology for asthma care, RespiraSense by PMD Solutions triumphed in the best digital technology for COPD care category, and NuvoAir Home from NuvoAir earned the award for best digital technology for both asthma and COPD care.

PMD Device Solutions (UK) Ltd recently completed their first full year submission and have achieved the level of "Standards Exceeded". Showcasing their commitment to data security and protection in handling NHS patient data. 

We are thrilled to announce that we have been accepted onto the prestigious @DigitalHealth.London Accelerator programme!

In recent years the acceleration of digital health has revolutionised the way medical professionals work.  The “Shift Left'' policies  of deploying innovative technology solutions to support specialised, integrated care from acute settings to the community are driven by the reimagining of traditional care being to be delivered digitally.  This includes intelligent and personalised remote monitoring solutions within acute hospital care as well as in the community setting.  The Covid-19 pandemic has accelerated the adoption of telemedicine and remote monitoring, leading to a paradigm shift in how patients are treated in the setting of their choosing. 

Respiratory Failure is a life-threatening condition where the lungs cannot provide the body's vital organs with enough oxygen. Respiratory failure occurs when the respiratory system fails to maintain gas exchange, resulting in hypoxia or hypercapnia making it difficult to breath. Respiratory Failure can come in a variety of forms

RespiraSense is the world's leading motion tolerant and continuous respiratory rate monitor. It is a plug and play telemetry system that will integrate seamlessly into hospitals with programmable alert settings for a localised alert generation to align with hospitals early warning scoring procedures.

One of the most important physiological tasks living organisms do is breathing.  The inhalation and exhalation are known as the respiratory cycle. Respiration rate is an important indicator of a patient's health. Recent evidence suggests an average adult respiratory rate is 20 breaths per minute; however, this changes when a patient is sick or critically ill.

As we near the end of the year, I think that it is safe to say we will never forget the year that is 2020. The year starting off as normal, nobody predicted that we would be spending so much time on zoom. A global pandemic was nowhere on the list of likely global risks that CEOs worried about. Among the loss we have experienced this year, of family members, friends and personal plans, we have united in our ambition to stay safe and stay at home. Together, we’ve protected each other.